FMP
PetVivo Holdings, Inc.
PETV
NASDAQ
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.
0.788 USD
-0.0518 (-6.57%)
About
ceo
Mr. John Lai
sector
Healthcare
industry
Medical - Devices
website
https://www.petvivo.com
exchange
NASDAQ
Description
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.
CIK
0001512922
ISIN
US7168174081
CUSIP
716817408
Address
5251 Edina Industrial Boulevar...
Phone
952 405 6216
Country
US
Employee
25
IPO Date
Sep 8, 2014
Key Executives
